Product Program year 2019 Source: CMS Open Payments

Lipitor

Drug Cardiovascular;Metabolic Disease

NDC 0071-0155-23

Open in the dashboard

General payments

$24,043

10 payments

Research payments

$3,773

1 payment

Through program year 2019, $24,043 in general payments and $3,773 in research payments were reported against Lipitor (Cardiovascular;Metabolic Disease).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $24,043 10
2019 Research $3,773 1

Breakdown

Who paid General payments · program year 2019
  1. Pfizer Inc. $24,043 10 payments
Top recipients General payments · program year 2019
  1. Stephen Stahl Carlsbad, CA $8,008 33% · 1 payment
  2. Jennifer Robinson Cardiovascular Disease · Iowa City, IA $7,903 33% · 3 payments
  3. David Waters Internal Medicine · San Francisco, CA $4,631 19% · 5 payments
  4. Sripal Bangalore Interventional Cardiology · New York, NY $3,500 15% · 1 payment

Each share is of general payments naming this product in 2019.

Specialties paid General payments · program year 2019
  1. Cardiovascular Disease Internal Medicine $7,903 49% · 1 practitioner
  2. Internal Medicine $4,631 29% · 1 practitioner
  3. Interventional Cardiology Internal Medicine $3,500 22% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2019
  1. California $12,640 53% · 2 recipients
  2. Iowa $7,903 33% · 1 recipient
  3. New York $3,500 15% · 1 recipient

Each share is of general payments naming this product in 2019 where a state was reported.

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

3,146

Prescriptions dispensed, refills included

Drug cost

$2,629,459

Paid at the pharmacy, in all

Prescribers

196

With 11 or more claims of it

Medicare Part D drugs matched to LIPITOR, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Lipitor Atorvastatin Calcium Same name 196 3,146 $2,629,459

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Brian Heaster Internal Medicine SC 131 $163,011 None on record
Alexander Cohen Family Practice SC 112 $152,412 None on record
Vanessa Kinney Nurse Practitioner SC 88 $125,840 None on record
Michael Barrett Family Practice SC 86 $119,928 None on record
Sophia Evans Nurse Practitioner SC 70 $101,389 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron
10 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record